Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation

计划入组 30 人 · 首次发布于 2014 年 5 月 29 日

The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers

首次发布于 2014 年 8 月 28 日

HeartStart FRx Defibrillator Event Registry

计划入组 1,400 人 · 首次发布于 2020 年 1 月 31 日

4SCAR-FRa

FRM-024

FRM-36143

Elahere Demonstrates Significant Survival Benefit in Phase III MIRASOL Trial for Platinum-Resistant Ovarian Cancer

Sutro Biopharma Reports Promising Results for Luvelta in Platinum-Resistant Ovarian Cancer Trial

Top Oncology Healthcare Trends of 2024: Prior Authorization, PBM Reform, and Patient Navigation Lead Discussion